DexCom, Inc. (DXCM)
USD 59.82
(-3.2%)
USD 59.82
(-3.2%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 541.5 Million USD | 58.7% |
| 2022 | 341.2 Million USD | 120.56% |
| 2021 | 154.7 Million USD | -68.66% |
| 2020 | 493.6 Million USD | 388.23% |
| 2019 | 101.1 Million USD | 179.54% |
| 2018 | -127.1 Million USD | -153.19% |
| 2017 | -50.2 Million USD | 23.48% |
| 2016 | -65.6 Million USD | -13.89% |
| 2015 | -57.6 Million USD | -157.14% |
| 2014 | -22.4 Million USD | 24.83% |
| 2013 | -29.8 Million USD | 45.32% |
| 2012 | -54.5 Million USD | -21.8% |
| 2011 | -44.74 Million USD | 18.89% |
| 2010 | -55.17 Million USD | -3.08% |
| 2009 | -53.52 Million USD | 3.01% |
| 2008 | -55.18 Million USD | -20.28% |
| 2007 | -45.87 Million USD | 1.55% |
| 2006 | -46.59 Million USD | -51.46% |
| 2005 | -30.76 Million USD | -120.61% |
| 2004 | -13.94 Million USD | -40.67% |
| 2003 | -9.91 Million USD | -28.63% |
| 2002 | -7.7 Million USD | -22.88% |
| 2001 | -6.27 Million USD | -58.21% |
| 2000 | -3.96 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 143.5 Million USD | -1.98% |
| 2024 Q3 | 134.6 Million USD | -6.2% |
| 2024 Q1 | 146.4 Million USD | -42.88% |
| 2023 Q4 | 256.3 Million USD | 112.34% |
| 2023 Q1 | 48.6 Million USD | -47.06% |
| 2023 Q2 | 115.9 Million USD | 138.48% |
| 2023 Q3 | 120.7 Million USD | 4.14% |
| 2023 FY | 541.5 Million USD | 58.7% |
| 2022 Q4 | 91.8 Million USD | -9.29% |
| 2022 FY | 341.2 Million USD | 120.56% |
| 2022 Q1 | 97.3 Million USD | 601.55% |
| 2022 Q2 | 50.9 Million USD | -47.69% |
| 2022 Q3 | 101.2 Million USD | 98.82% |
| 2021 Q2 | 62.9 Million USD | 56.08% |
| 2021 Q3 | 70.9 Million USD | 12.72% |
| 2021 Q1 | 40.3 Million USD | -88.65% |
| 2021 FY | 154.7 Million USD | -68.66% |
| 2021 Q4 | -19.4 Million USD | -127.36% |
| 2020 Q4 | 355.2 Million USD | 391.97% |
| 2020 Q1 | 19.9 Million USD | -78.53% |
| 2020 Q3 | 72.2 Million USD | 55.94% |
| 2020 FY | 493.6 Million USD | 388.23% |
| 2020 Q2 | 46.3 Million USD | 132.66% |
| 2019 Q2 | -10.5 Million USD | 60.97% |
| 2019 FY | 101.1 Million USD | 179.54% |
| 2019 Q4 | 92.7 Million USD | 102.4% |
| 2019 Q1 | -26.9 Million USD | 85.03% |
| 2019 Q3 | 45.8 Million USD | 536.19% |
| 2018 FY | -127.1 Million USD | -153.19% |
| 2018 Q1 | -24.2 Million USD | -157.45% |
| 2018 Q2 | 30.2 Million USD | 224.79% |
| 2018 Q3 | 46.6 Million USD | 54.3% |
| 2018 Q4 | -179.7 Million USD | -485.62% |
| 2017 Q2 | 2.9 Million USD | 106.95% |
| 2017 Q3 | -2 Million USD | -168.97% |
| 2017 FY | -50.2 Million USD | 23.48% |
| 2017 Q4 | -9.4 Million USD | -370.0% |
| 2017 Q1 | -41.7 Million USD | -463.51% |
| 2016 Q3 | -18.8 Million USD | 6.93% |
| 2016 Q2 | -20.2 Million USD | -5.21% |
| 2016 Q4 | -7.4 Million USD | 60.64% |
| 2016 FY | -65.6 Million USD | -13.89% |
| 2016 Q1 | -19.2 Million USD | -1380.0% |
| 2015 FY | -57.6 Million USD | -157.14% |
| 2015 Q4 | 1.5 Million USD | 103.53% |
| 2015 Q3 | -42.5 Million USD | -1048.65% |
| 2015 Q2 | -3.7 Million USD | 71.32% |
| 2015 Q1 | -12.9 Million USD | -1092.31% |
| 2014 Q3 | -5.2 Million USD | 13.33% |
| 2014 Q4 | 1.3 Million USD | 125.0% |
| 2014 FY | -22.4 Million USD | 24.83% |
| 2014 Q1 | -12.5 Million USD | -380.77% |
| 2014 Q2 | -6 Million USD | 52.0% |
| 2013 FY | -29.8 Million USD | 45.32% |
| 2013 Q4 | -2.6 Million USD | 56.67% |
| 2013 Q2 | -10.1 Million USD | 9.01% |
| 2013 Q1 | -11.1 Million USD | -30.87% |
| 2013 Q3 | -6 Million USD | 40.59% |
| 2012 Q3 | -17.26 Million USD | -17.51% |
| 2012 Q2 | -14.69 Million USD | -4.46% |
| 2012 Q1 | -14.06 Million USD | -14.8% |
| 2012 FY | -54.5 Million USD | -21.8% |
| 2012 Q4 | -8.48 Million USD | 50.87% |
| 2011 Q4 | -12.25 Million USD | 7.73% |
| 2011 Q3 | -13.27 Million USD | -80.24% |
| 2011 Q2 | -7.36 Million USD | 37.83% |
| 2011 Q1 | -11.85 Million USD | -20.77% |
| 2011 FY | -44.74 Million USD | 18.89% |
| 2010 Q2 | -11.68 Million USD | 42.35% |
| 2010 Q1 | -20.27 Million USD | -75.84% |
| 2010 Q4 | -9.81 Million USD | 26.77% |
| 2010 Q3 | -13.39 Million USD | -14.64% |
| 2010 FY | -55.17 Million USD | -3.08% |
| 2009 Q3 | -13.52 Million USD | 11.79% |
| 2009 FY | -53.52 Million USD | 3.01% |
| 2009 Q4 | -11.52 Million USD | 14.75% |
| 2009 Q2 | -15.33 Million USD | -16.65% |
| 2009 Q1 | -13.14 Million USD | 2.29% |
| 2008 Q4 | -13.45 Million USD | 8.43% |
| 2008 FY | -55.18 Million USD | -20.28% |
| 2008 Q2 | -14.07 Million USD | -8.5% |
| 2008 Q1 | -12.97 Million USD | -6.08% |
| 2008 Q3 | -14.68 Million USD | -4.36% |
| 2007 Q1 | -10.92 Million USD | 1.31% |
| 2007 Q2 | -11.33 Million USD | -3.72% |
| 2007 Q3 | -11.38 Million USD | -0.42% |
| 2007 Q4 | -12.22 Million USD | -7.42% |
| 2007 FY | -45.87 Million USD | 1.55% |
| 2006 Q4 | -11.07 Million USD | 17.59% |
| 2006 FY | -46.59 Million USD | -51.46% |
| 2006 Q3 | -13.43 Million USD | -20.32% |
| 2006 Q2 | -11.16 Million USD | -2.29% |
| 2006 Q1 | -10.91 Million USD | 9.52% |
| 2005 Q1 | -5.98 Million USD | 0.0% |
| 2005 Q4 | -12.06 Million USD | -90.65% |
| 2005 Q3 | -6.32 Million USD | 0.86% |
| 2005 Q2 | -6.38 Million USD | -6.65% |
| 2005 FY | -30.76 Million USD | -120.61% |
| 2004 FY | -13.94 Million USD | -40.67% |
| 2003 FY | -9.91 Million USD | -28.63% |
| 2002 FY | -7.7 Million USD | -22.88% |
| 2001 FY | -6.27 Million USD | -58.21% |
| 2000 FY | -3.96 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | -61.61 Million USD | 978.802% |
| BrainsWay Ltd. | -4.19 Million USD | 13002.073% |
| Cerus Corporation | -37.48 Million USD | 1544.424% |
| Envoy Medical, Inc. | -29.9 Million USD | 1910.552% |
| electroCore, Inc. | -18.83 Million USD | 2975.119% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | 6218.644% |
| IceCure Medical Ltd | -14.65 Million USD | 3795.741% |
| Inogen, Inc. | -102.44 Million USD | 628.556% |
| OrthoPediatrics Corp. | -20.97 Million USD | 2681.768% |
| Lucid Diagnostics Inc. | -52.66 Million USD | 1128.178% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | 4039.552% |
| MaxCyte, Inc. | -37.92 Million USD | 1527.893% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | 4665.963% |
| Nexalin Technology, Inc. | -4.64 Million USD | 11748.395% |
| Orthofix Medical Inc. | -151.39 Million USD | 457.674% |
| PAVmed Inc | -64.17 Million USD | 943.787% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | 1132.077% |
| RxSight, Inc. | -48.6 Million USD | 1214.014% |
| Sight Sciences, Inc. | -55.54 Million USD | 1074.85% |
| SI-BONE, Inc. | -43.33 Million USD | 1349.538% |
| TELA Bio, Inc. | -46.66 Million USD | 1260.423% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | 1193.343% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | 4086.601% |
| Acutus Medical, Inc. | -81.66 Million USD | 763.091% |
| Talis Biomedical Corporation | -62 Million USD | 973.288% |
| Spectral AI, Inc. | -20.85 Million USD | 2696.624% |
| Nano-X Imaging Ltd. | -60.77 Million USD | 990.977% |
| CVRx, Inc. | -41.19 Million USD | 1414.352% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | -84483.471% |
| PetVivo Holdings, Inc. | -10.95 Million USD | 5042.815% |
| Bioventus Inc. | -156.23 Million USD | 446.604% |
| Venus Concept Inc. | -37.25 Million USD | 1553.691% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | 1017.206% |
| LivaNova PLC | 17.54 Million USD | -2986.173% |
| 908 Devices Inc. | -36.39 Million USD | 1587.678% |
| Alphatec Holdings, Inc. | -186.63 Million USD | 390.134% |
| Nemaura Medical Inc. | -14.14 Million USD | 3928.55% |
| NeuroPace, Inc. | -32.95 Million USD | 1743.1% |
| LENSAR, Inc. | -14.38 Million USD | 3864.861% |
| Apyx Medical Corporation | -18.71 Million USD | 2993.71% |
| Cutera, Inc. | -162.83 Million USD | 432.549% |
| STRATA Skin Sciences, Inc. | -10.83 Million USD | 5100.0% |
| BioSig Technologies, Inc. | -29.04 Million USD | 1964.605% |
| Anika Therapeutics, Inc. | -82.66 Million USD | 755.038% |
| ClearPoint Neuro, Inc. | -22.08 Million USD | 2551.446% |
| Integra LifeSciences Holdings Corporation | 67.74 Million USD | -699.368% |
| Axonics, Inc. | -6.08 Million USD | 8994.547% |
| Outset Medical, Inc. | -172.79 Million USD | 413.373% |
| IRIDEX Corporation | -9.57 Million USD | 5758.307% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | 611.346% |
| IRadimed Corporation | 17.19 Million USD | -3049.579% |
| Tivic Health Systems, Inc. | -8.24 Million USD | 6668.413% |
| INVO Bioscience, Inc. | -8.03 Million USD | 6839.591% |
| Telesis Bio, Inc. | -47.72 Million USD | 1234.649% |
| Viemed Healthcare, Inc. | 10.24 Million USD | -5186.537% |
| Varex Imaging Corporation | -47.7 Million USD | 1235.22% |
| Quipt Home Medical Corp. | -2.78 Million USD | 19550.431% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 4897.98% |
| Pulmonx Corporation | -60.84 Million USD | 989.996% |
| Dynatronics Corporation | -2.69 Million USD | 20172.513% |
| Modular Medical, Inc. | -17.47 Million USD | 3199.599% |
| ReShape Lifesciences Inc. | -11.38 Million USD | 4855.423% |
| Semler Scientific, Inc. | 20.58 Million USD | -2530.812% |
| InMode Ltd. | 197.91 Million USD | -173.597% |
| Bruker Corporation | 427.2 Million USD | -26.756% |
| Cytosorbents Corporation | -28.5 Million USD | 1999.507% |
| Align Technology, Inc. | 445.05 Million USD | -21.671% |
| Viveve Medical, Inc. | -22.02 Million USD | 2558.347% |
| ZimVie Inc. | -393.28 Million USD | 237.687% |
| Movano Inc. | -29.28 Million USD | 1949.196% |
| Cytek Biosciences, Inc. | -12.14 Million USD | 4557.524% |
| Nexalin Technology, Inc. | -4.64 Million USD | 11748.395% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | -84483.471% |
| Tandem Diabetes Care, Inc. | -222.61 Million USD | 343.249% |
| Profound Medical Corp. | -28.56 Million USD | 1995.411% |
| Insulet Corporation | 206.3 Million USD | -162.482% |
| enVVeno Medical Corporation | -23.51 Million USD | 2402.688% |
| Surmodics, Inc. | -11.54 Million USD | 4791.561% |
| iCAD, Inc. | -4.84 Million USD | 11271.859% |
| Nuwellis, Inc. | -20.2 Million USD | 2779.499% |
| Biotricity, Inc. | -14.09 Million USD | 3941.983% |
| iRhythm Technologies, Inc. | -123.4 Million USD | 538.796% |
| Aethlon Medical, Inc. | -12.2 Million USD | 4535.553% |
| InspireMD, Inc. | -19.91 Million USD | 2818.919% |
| PAVmed Inc. | -64.17 Million USD | 943.787% |
| BIOLASE, Inc. | -20.63 Million USD | 2724.564% |
| Beyond Air, Inc. | -60.24 Million USD | 998.875% |
| FONAR Corporation | 10.56 Million USD | -5024.252% |
| AxoGen, Inc. | -21.71 Million USD | 2593.553% |
| Vivani Medical, Inc. | -25.65 Million USD | 2210.947% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | -1799.001% |
| Inari Medical, Inc. | -1.63 Million USD | 33199.022% |
| UFP Technologies, Inc. | 44.92 Million USD | -1105.369% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | 10650.759% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | 8298.076% |
| Tenon Medical, Inc. | -15.58 Million USD | 3575.387% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | 3610.307% |
| Co-Diagnostics, Inc. | -35.33 Million USD | 1632.567% |
| AdaptHealth Corp. | -678.89 Million USD | 179.762% |
| Sintx Technologies, Inc. | -8.25 Million USD | 6656.484% |
| NanoVibronix, Inc. | -3.71 Million USD | 14691.754% |
| Quanterix Corporation | -32.33 Million USD | 1774.708% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 4897.98% |
| Sensus Healthcare, Inc. | 485 Thousand USD | -111549.485% |
| Pacific Biosciences of California, Inc. | -306.73 Million USD | 276.537% |
| TransMedics Group, Inc. | -25.02 Million USD | 2263.577% |
| ReWalk Robotics Ltd. | -22.13 Million USD | 2546.573% |
| NeuroMetrix, Inc. | -6.52 Million USD | 8393.148% |
| Hyperfine, Inc. | -44.23 Million USD | 1324.061% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | 789.791% |
| Biomerica, Inc. | -5.97 Million USD | 9158.213% |
| Bone Biologics Corporation | -8.94 Million USD | 6151.137% |
| AVITA Medical, Inc. | -39.16 Million USD | 1482.498% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | 5540.085% |
| Silk Road Medical, Inc | -55.74 Million USD | 1071.422% |